ABILIFY N: A Novel Treatment for Schizophrenia Schizophrenia is a chronic neurological disorder characterized by disturbances in thought and emotion, and an inability to recognize reality (Rosen & Seligman, 2017). To date, treatments for schizophrenia have been limited to antipsychotic medications. However, a new novel treatment option, ABILIFY N, has recently been developed and is […]
Introduction and Classification Aripiprazole is a modern pharmaceutical agent classified as an atypical antipsychotic, often referred to as a second-generation antipsychotic (SGA). It represents a significant advancement in the pharmacological management of severe mental illnesses, distinguishing itself from older, typical antipsychotics primarily through its unique mechanism of action and generally improved side effect profile regarding […]